Extending potentially curative options for older patients with PCNSL
Affiliation
Division of Cancer Sciences, University of Manchester, Manchester, UK; The Christie Hospital, Manchester M204BX, UKIssue Date
2024
Metadata
Show full item recordCitation
Phillips EH, Cwynarski K. Extending potentially curative options for older patients with PCNSL. LANCET HAEMATOLOGY. 2024 MAR;11(3):e171-e3. PubMed PMID: WOS:001201206000001. English.Journal
Lancet HaematologyDOI
10.1016/S2352-3026(23)00367-8PubMed ID
38301671Additional Links
https://dx.doi.org/10.1016/S2352-3026(23)00367-8Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/S2352-3026(23)00367-8
Scopus Count
Collections
Related articles
- Primary central nervous system lymphoma in older adults and the rationale for maintenance strategies: a narrative review.
- Authors: Tsang M, Rubenstein JL, Pulczynski EJ
- Issue date: 2021 Sep
- Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma.
- Authors: Wendler J, Fox CP, Valk E, Steinheber C, Fricker H, Isbell LK, Neumaier S, Okosun J, Scherer F, Ihorst G, Cwynarski K, Schorb E, Illerhaus G
- Issue date: 2022 Sep 10
- Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients.
- Authors: Schorb E, Finke J, Ihorst G, Kasenda B, Fricker H, Illerhaus G
- Issue date: 2019 Mar 29
- Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.
- Authors: Uldrick TS, Pipkin S, Scheer S, Hessol NA
- Issue date: 2014 Jan 28
- Biology and treatment of primary central nervous system lymphoma.
- Authors: Algazi AP, Kadoch C, Rubenstein JL
- Issue date: 2009 Jul